Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019380
Filing Date
2024-07-08
Accepted
2024-07-08 18:26:03
Documents
1
Period of Report
2024-07-05

Document Format Files

Seq Description Document Type Size
1 form4-07082024_100700.html 4  
1 form4-07082024_100700.xml 4 4093
  Complete submission text file 0001415889-24-019380.txt   5547
Mailing Address C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
Van Hauwermeiren Timothy (Reporting) CIK: 0001816206 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241106015

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)